Results 51 to 60 of about 12,085 (139)

Effects of a neurokinin-1 receptor antagonist in the acute phase after thoracic spinal cord injury in a rat model. [PDF]

Front Mol Neurosci, 2023
Zheng G, Harms AK, Tail M, Zhang H, Nimmo A, Skutella T, Kiening K, Unterberg A, Zweckberger K, Younsi A.   +9 more
europepmc   +1 more source

Neurokinin-1 receptor is highly expressed in cervical cancer and its antagonist induces cervical cancer cell apoptosis. [PDF]

Eur J Histochem, 2023
Guan L, Yuan S, Ma J, Liu H, Huang L, Zhang F.   +5 more
europepmc   +1 more source

Aprepitant, a Neurokinin-1 Receptor Antagonist, as a Disruptive Drug for the Treatment of Pediatric Cancer. [PDF]

J Clin Med
Rosso M, Alcaide C, Muñoz M.
europepmc   +1 more source

Netupitant versus aprepitant: model-predicted neurokinin-1 receptor occupancy and implications for long-delayed nausea and vomiting prevention. [PDF]

Support Care Cancer
Iihara H, Bianchini G, Aapro M, Licata L, Bernareggi A, Navari RM, Park YH, Jordan K, Vidal M, Scotté F, Roeland EJ, Schwartzberg L, Rugo HS.   +12 more
europepmc   +1 more source

The substance P/ Neurokinin-1 receptor signaling drives perineural invasion in pancreatic ductal adenocarcinoma (PDAC). [PDF]

Front Cell Dev Biol
Schiedlauske K, Biskup S, Hofer L, Deipenbrock A, Çifcibaşı K, Demir IE, Esposito I, Weyhe D, Teusch NE.   +8 more
europepmc   +1 more source

Association of co-administration of neurokinin-1 receptor antagonists and dexamethasone with new-onset diabetes in patients receiving chemotherapy: a retrospective cross-sectional study using health claims database in Japan. [PDF]

Support Care Cancer
Ozawa Y, Suzuki S, Koinuma T, Yokokawa T, Ichimura T, Suzuki K, Hori Y, Imai S.   +7 more
europepmc   +1 more source

Exploring neurokinin-1 receptor antagonism for depression with structurally differentiated inhibitors. [PDF]

Exp Mol Med
Yoo H, Boo KJ, Nguyen LP, Hwang JI, Lee CS, Yang SH, Jeon SJ, Kim HR, Kim H.   +8 more
europepmc   +1 more source

Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance. [PDF]

Cancers (Basel), 2022
García-Aranda M, Téllez T, McKenna L, Redondo M.   +3 more
europepmc   +1 more source

Neurokinin-1 receptor activation protects against cardiac fibrosis, inflammation and diastolic dysfunction in type 2 diabetic mice. [PDF]

Br J Pharmacol
Widiapradja A, Connery H, Helmick BJ, Schafner KJ, Manchikalapudi V, Horvath H, Gugino S, Kriska T, Herrnreiter A, DeVallance E, Campbell WB, Levick SP.   +11 more
europepmc   +1 more source

GPCR large-amplitude dynamics by ¹⁹F-NMR of aprepitant bound to the neurokinin 1 receptor. [PDF]

Proc Natl Acad Sci U S A, 2022
Pan B, Liu D, Yang L, Wüthrich K.
europepmc   +1 more source